Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

By G. Garcia‐Tsao, J. Abraldes, A. Berzigotti, J. Bosch. Hepatology, 2017

1,962 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/cd37e3022233002c24929f4ff83d550bea971d9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Bernardi
2. Aleksander Krag
3. C. Francoz
4. C. Villanueva
5. J. Trebicka
6. W. Laleman
7. P. Ginés
8. P. Angeli

In Hepatology

1. M. Bernardi
2. Aleksander Krag
3. C. Francoz
4. C. Villanueva
5. J. Trebicka
6. W. Laleman
7. P. Ginés
8. P. Angeli

Citations in the corpus

• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “Despite therapy with vasoactive drugs plus EBL and prophylactic antibiotics, up to 10– 15% of patients with AVH have persistent bleeding or early rebleeding [195,199].”